Statin-induced myopathy: a review and update

@article{Abd2011StatininducedMA,
  title={Statin-induced myopathy: a review and update},
  author={Thura T. Abd and Terry A Jacobson},
  journal={Expert Opinion on Drug Safety},
  year={2011},
  volume={10},
  pages={373 - 387}
}
  • Thura T. Abd, Terry A Jacobson
  • Published 2011
  • Medicine
  • Expert Opinion on Drug Safety
  • Introduction: Statin-induced myopathy is an important cause of statin intolerance and the most common cause of statin discontinuation. Observational studies estimate that 10 – 15% of statin users develop statin-related muscle side effects ranging from mild myalgia to more severe muscle symptoms with significant CPK elevations. Areas covered: This article reviews the epidemiology, clinical features, risk factors and mechanisms of statin-induced myopathy and provides an evidence-based algorithm… CONTINUE READING

    Citations

    Publications citing this paper.
    SHOWING 1-10 OF 202 CITATIONS, ESTIMATED 51% COVERAGE

    Management of statin intolerance

    VIEW 1 EXCERPT
    CITES BACKGROUND

    Statin induced myotoxicity.

    FILTER CITATIONS BY YEAR

    2011
    2020

    CITATION STATISTICS

    • 12 Highly Influenced Citations

    • Averaged 16 Citations per year from 2018 through 2020

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 109 REFERENCES

    Evidence-Based Management of Statin Myopathy

    VIEW 1 EXCERPT

    Narrative Review: Statin-Related Myopathy

    VIEW 2 EXCERPTS

    Statin myopathy: a review of recent progress

    VIEW 1 EXCERPT

    The genetics of statin-induced myopathy.

    VIEW 3 EXCERPTS
    HIGHLY INFLUENTIAL

    Statin myopathy: Incidence, risk factors, and pathophysiology

    VIEW 7 EXCERPTS
    HIGHLY INFLUENTIAL

    Current overview of statin-induced myopathy.

    VIEW 1 EXCERPT

    Statin-associated myopathy.

    VIEW 1 EXCERPT